What is Maximum Human Performance?
Maximum Human Performance operates as a premier entity in the sports supplementation industry, specializing in high-quality formulations for performance recovery, protein synthesis, and metabolic optimization. With a history spanning over 25 years, the company has established a robust reputation for delivering innovative, GMP-certified products manufactured within the United States. By targeting the intersection of athletic performance and general health, the brand has cultivated a loyal consumer base that relies on its rigorous scientific standards and proven efficacy. The company's market position is defined by its ability to bridge the gap between professional-grade athletic requirements and the broader consumer wellness market, ensuring a diversified revenue stream across multiple product categories.
How much funding has Maximum Human Performance raised?
Maximum Human Performance has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Maximum Human Performance
PPP
Public-Private Partnership
What's next for Maximum Human Performance?
Looking ahead, the strategic deployment of this capital will likely center on expanding the company's international market presence and diversifying its product portfolio to address emerging trends in personalized nutrition. Given the late-stage nature of this financing, the firm is expected to prioritize operational efficiency and potential inorganic growth opportunities, such as strategic acquisitions or partnerships that complement its existing manufacturing capabilities. By maintaining its focus on science-backed innovation, Maximum Human Performance is poised to capitalize on the increasing global demand for high-performance health solutions, further cementing its status as a leader in the sports nutrition ecosystem.
See full Maximum Human Performance company page
